Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Dialysis access · Delaware | Dialysis access · Texas | |
|---|---|---|
| Surgeons, 2024 | 7 | 153 |
| Medicare fee-for-service cases | 781 | 14,652 |
| Growth since 2019 (Medicare FFS) | −12%/yr | −16%/yr |
| Forecast cases (Medicare FFS) | 780 in 2030 | 14,800 in 2030 |
| Forecast growth | 0%/yr to 2030 | +0.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.7 | 7.1 |
| Medicare Advantage share | 35% | 59% |
| Out of hospital | 89% (+2 pts since 2019) | 71% (−1 pts since 2019) |
| Cases per surgeon | 112 | 96 |
| Top 10 surgeons' share | 100% | 26% |
| Surgeons growing | 0 | 8 |
| New since the base year | 0 | 21 |
| Likely to stop billing it | 0 by 2026 | 20 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $68 | $148 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.